Alzheimer's Society, study participant Eric Deeson and Sir Prof John Hardy comment on the disappointing clinical trial results for Alzheimer's drug gantenerumab.

Dr Richard Oakley, Associate Director of Research at Alzheimer’s Society, comments on news surrounding breakthrough Alzheimer's drug lecanemab.

Alzheimer’s Society reveals most unforgettable moments on the pitch on England team’s 150th birthday.

Bill and Jo's Heart-breaking story illustrates how people with dementia ‘face being abandoned’ as care workers struggle to make ends meet.

Survey of nearly 2,000 people affected by dementia reveals less than half felt care staff had a good understanding of dementia and one in four didn’t feel at all involved in the planning of their care.

The Care Quality Commissions (CQC)'s annual assessment of the state of health and social care in England launches Friday 21 October 2022, looking at quality of care over the past year.